Skip to content

Acute Phase Proteins as Early Markers in Sepsis

Acute Phase Proteins as Early Markers in Sepsis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00641355
Enrollment
15
Registered
2008-03-24
Start date
2008-04-30
Completion date
2012-09-30
Last updated
2008-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

Monitoring of different serumproteins after severe trauma and during trauma-induced sepsis. * Trial with surgical intervention

Interventions

PROCEDURENo intervention

No intervention

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with severe trauma (ISS score \> 16), both genders, patients on ICU

Exclusion criteria

* Moribund patients (pH \<7,1, lactate \>15mmol, Basedeficit \> 15mEq/L, severe heart or liver injuries, GCS never over 5 after trauma) * Severe head injuries (AIS head \>4) * Patient with severe infectious diseases, or diseases which severely affect the immune system (diabetes, Alkohol or nicotine abuse) * Non-german speaking patients

Countries

Switzerland

Contacts

Primary Contact01 Studienregister MasterAdmins
+41 (0)44 255 11 11

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026